ZIC
ABMD

ZWJ Investment Counsel’s Abiomed Inc ABMD Stock Holding History

ZWJ Investment Counsel’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,000
Closed -$257K – 164
2016
Q3 		$257K Hold
2,000
– – 0.03% 131
2016
Q2 		$219K Buy
+2,000
New +$199K 0.02% 143

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ZWJ Investment Counsel's ABMD Position: Q4 2016 in Review

ZWJ Investment Counsel sold out of Abiomed Inc (ABMD) in Q4 2016, closing a stake of 2,000 shares — an estimated $257K sold.

ZWJ Investment Counsel first reported a position in ABMD in Q2 2016 and held it in 2 quarters. The position peaked at $257K in Q3 2016. 297 funds tracked by Wall St. Rank hold ABMD as of Q4 2016.

  • ZWJ Investment Counsel reported no remaining Abiomed Inc position as of Q4 2016 after selling out during the quarter.
  • ZWJ Investment Counsel sold 2,000 Abiomed Inc shares in Q4 2016, an estimated $257K.
  • ZWJ Investment Counsel first reported a position in Abiomed Inc in Q2 2016 and held it in 2 quarters.
  • ZWJ Investment Counsel's Abiomed Inc position peaked at $257K in Q3 2016.
  • 297 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2016.

Based on ZWJ Investment Counsel's 13F filing for Q4 2016, filed 6 Feb 2017.